Medicare Advantage enrollment continued to climb in 2022
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage enrollment continued to accelerate in 2022, an updated analysis from Chartis
Read More
CMS
CMS to phase in Medicare Advantage risk adjustment changes, bumping payments by 3%
(By Rylee Wilson for Becker’s Hospital Review) CMS will move ahead with Medicare Advantage risk adjustment changes payers and some
Read MoreA Progress Check on Hospital Price Transparency
(By Michelle Andrews for Kaiser Health News) For decades, U.S. hospitals have generally stonewalled patients who wanted to know ahead
Read MoreReducing Medicare Advantage benchmark payments will slightly reduce benefits, study finds
(By Rylee Wilson for Becker’s Hospital Review) Reduced Medicare Advantage benchmark payments would likely have a small effect on premiums,
Read MorePayers spending ‘buckets of money’ lobbying against Medicare Advantage rate changes
(By Rylee Wilson for Becker’s Hospital Review) The insurance industry is mounting its largest lobbying fight in years against CMS’
Read MoreHHS Releases Initial Guidance for Historic Medicare Drug Price Negotiation Program for Price Applicability Year 2026
(Source – www.cms.gov) For the first time in history, Medicare will have the ability to negotiate lower prescription drug prices
Read MoreWhy Medicare is suddenly under debate again
By Micel Martin, Tinbete Ermyas, Gurjit Kaur for npr on March 14, 2023 The White House released President Biden’s $6.8
Read MoreProviders join payers in urging CMS to halt proposed 2024 Medicare Advantage rates
(By Rylee Wilson for Becker’s Hospital Review) Provider groups are joining in payers’ concerns about CMS’ proposed changes to Medicare
Read MoreInsurers urge CMS to reverse course on ‘flawed’ MA risk adjustment changes
(By Rylee Wilson for Becker’s Hospital Review) Insurers are urging CMS not to implement proposed risk adjustment changes in Medicare
Read MoreBiden proposes expanding Medicare drug negotiation program
(By Rachel Cohrs for STAT) WASHINGTON — The Biden administration will propose expanding Democrats’ new drug pricing law by allowing
Read More